http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_63ab37ce66d9c99198b156f3d2e02cb9
Outgoing Links
| Predicate | Object |
|---|---|
| family-name | Michelakis |
| name | Evangelos D Michelakis Evangelos D. Michelakis |
| given-name | Evangelos D Evangelos D. |
| organization-name | *Pulmonary Hypertension Program, University of Alberta, Edmonton, AB, Canada IGG 2B7; and From the Department of Medicine, University of Alberta, Edmonton, Canada (R.P., G.S., V.G., P.D., A.H., E.D.M.); and Pulmonary Hypertension Research Group, Department of Medicine, Laval University, CRIUCPQ, Québec City, QC, Canada (S.P., S.B.). From the Department of Medicine (Cardiology), University of Alberta, Edmonton, AB, Canada. From the Department of Medicine (Cardiology) and Vascular Biology Group (E.D.M., M.S.M., X.-C.W., J.R.B.D., R.M., L.P., R.W., S.L.A.), and the Department of Pediatrics and Cardiovascular Research Group (J.R.B.D., T.A.H., G.D.L.), University of Alberta, Edmonton, Canada. From Vascular Biology Group (H.K., K.H., S.N.B., A.H., G.H., R.M., B.T., E.D.M., S.L.A.), Alberta Cardiovascular and Stroke Research Centre (ABACUS), Department of Physiology (S.L.A.), Division of Cardiac Surgery (I.R.), University of Alberta, Edmonton, Canada; and Department of Pediatric Cardiology (T.N.), Heart Institute of Japan, Tokyo Women’s Medical University, Tokyo, Japan. From the Department of Medicine and Pediatrics (J.R.B.D.) and the Vascular Biology Group (M.S.M., S.B., X.W., J.R.B.D., A.H., K.H., E.D.M.), University of Alberta, Edmonton, Canada. Cardiovascular Section (111C), Minneapolis VA Medical Center From the Division of Cardiology, Department of Medicine, University of Alberta, 2C2 Walter Mackenzie Centre, Edmonton, Canada. From the Cardiovascular Research Group, Departments of Pediatrics (J.R.B.D., G.D.L.), Pharmacology (J.R.B.D., T.A.H., G.D.L.), and Medicine (S.B., E.D.M.), Faculty of Medicine, University of Alberta, Edmonton, Alberta, Canada; USDA/ARS Children’s Nutrition Research Center, Baylor College of Medicine, Department of Pediatrics, Houston, Tex (M.E.Y.); and Chugai Research Institute for Medical Science, Inc, Komakado Gotemba, Japan (M.W., Y.K., K.J.). From the Pulmonary Hypertension Program (J.N., V.G., R.M., A.H., L.W., E.D.M.), Division of Cardiac Surgery, Department of Surgery (J.N., I.M.R., D.B.R.), and Department of Pharmacology (D.S., C.S.A., P.E.L., J.R.B.D.), University of Alberta, Alberta, Edmonton, Canada; and Section of Cardiology, Department of Medicine, University of Chicago, Chicago, Ill (S.L.A.). From the Vascular Biology Group and Pulmonary Hypertension Program, Department of Medicine (E.D.M., W.T., L.W., X.-C.W., S.L.A.), the Department of Diagnostic Imaging (M.N.), Division of Pulmonary Medicine (D.L.), and Department of Surgery (Cardiothoracic) (S.-H.W., D.M.), University of Alberta, Edmonton, Canada. From the Vascular Biology Group, Division of Cardiology (S.B., E.D.M., B.T., S.B., A.H., G.H., R.M., M.S.M., S.L.A.), Physiology Department (S.L.A.), and Department of Pediatrics (B.T.), University of Alberta, Edmonton, Canada; Department of Medicine (Cardiology) (E.K.W.), Minneapolis Veterans Affairs Medical Center, Minneapolis, Minn; and Ontario Genomics Innovation Centre (C.J.P., M.A.A.-N.), Ottawa Health Research Institute, Ottawa, Ontario. Department of Medicine, University of Alberta, Edmonton, Canada From the Pulmonary Vascular Disease Center, Department of Medicine, University of Pittsburgh Medical Center, Pa (H.C.C.); Pulmonary Hypertension Program and Division of Pulmonary and Critical Care Medicine (P.M.H.), Johns Hopkins Medical Institutions, Baltimore, Md; Pulmonary Hypertension Program, Department of Medicine (Cardiology), University of Alberta, Alberta, Edmonton, Canada (E.D.M.); and Pulmonary Vascular Research Institute, Chicago, Ill (H.C.C., E.D.M., P.M.H.). Department of Medicine University of Alberta Edmonton Canada From the Division of Cardiology, Department of Medicine, University of Alberta, Edmonton, Canada (P.D., R.P., G.S., A.C.Q., E.D.M.); and Department of Medicine, Laval University, Quebec City, Canada (S.B.). From the Department of Medicine, Laval University, Pulmonary Hypertension Research Group, IUCPQ Research Centre, Québec, Canada (J.M., A.P., M.V., F.P., C.G., A.C., S.B.-B., E.T., C.C., S.P., S.B.); and Vascular Biology Research Group, Department of Medicine, University of Alberta, Edmonton, Canada (R.P., S.Z., E.D.M.). Department of Medicine, University of Alberta, Edmonton, T6G2B7, Canada; From the Department of Medicine, Université Laval, Québec City, Quebec (S.B., R.P., M.R.), and Department of Medicine (Cardiology) and Cardiovascular Research Group, Faculty of Medicine and Dentistry (G.S., P.D., K.O.W., J.N., A.H., J.R.B.D., E.D.M.), University of Alberta, Edmonton, Alberta, Canada. Departments of Medicine (Cardiology) and University of Alberta, Edmonton, Alberta, Canada Pulmonary Hypertension Program, Department of Medicine, University of Alberta, Edmonton, Alberta, Canada T6G 2B7.; Cardiovascular Research Center, University of Alberta, Edmonton, Alberta, Canada T6G 2B7. Vascular Biology Group, Cardiology Division, University of Alberta School of Medicine, Edmonton; and; Physiology Department, University of Alberta, Edmonton, Alberta T6G 2B7, Canada Vascular Biology GroupDepartment of MedicineDivision of CardiologyUniversity of AlbertaEdmontonCanada Department of Medicine, University of Alberta, Edmonton, Alberta, Canada From the Vascular Biology Research Group (B.T., F.L., E.D.M., M.S., F.E., K.H., G.H., A.H., S.L.A.), the Department of Pediatrics, Division of Neonatology (B.T.), the Department of Medicine (E.D.M., S.L.A.), the Surgical-Medical Research Institute (G.K.), and the Department of Physiology (S.L.A.), University of Alberta, Edmonton, Canada; and Regeneron Pharmaceuticals Inc, Tarrytown, NY (G.T.). From Pulmonary Hypertension Research Group of the Institut Universitaire de Cardiologie et de Pneumologie de Québec Research Center, Laval University, Quebec City, QC, Canada (F.P., G.R., A.D., C.T., S.B.-B., E.T., V.N., R. Paradis, C.G., R.W., I.J., A.C.L., J.P., E.C., P.J., P.P., S.P., S.B.); and Vascular Biology Research Group, Department of Medicine, University of Alberta, Edmonton, AB, Canada (R. Paulin, E.D.M.). Cardiology Division, Department of Medicine, University of Alberta, WMC 2C2,36, 8440 112th Street, Edmonton, Alta., Canada T6G 2B7. From the Vascular Biology Group, Cardiology, University of Alberta, Edmonton, Canada. University of Alberta Hospitals, 2C2 Walker C McKenzie Health Sciences, Centre, Edmonton, Canada. From the Pulmonary Hypertension Program, Department of Medicine (Cardiology Division), University of Alberta, Edmonton, Alberta, Canada (E.D.M.); Division of Experimental Medicine, Imperial College of Medicine, London, UK (M.R.W.); Cardiopulmonary Research Program, Department of Pediatrics, Stanford University, Stanford, Calif (M.R.); and Pulmonary Vascular Research Institute, Canterbury, UK (E.D.M., M.R.W., M.R.). From the Cardiology Division and the Vascular Biology Group, Department of Medicine (E.D.M., X.W., A.N., B.T., K.H., J.R.B.D., A.H., G.H., S.L.A.), the Division of Cardiac Surgery (I.R.), the Cardiovascular Research Group (A.B.), and the Department of Physiology (S.L.A.), University of Alberta, Alberta, Canada. From the Department of Medicine, University of Alberta, Edmonton, Canada. Department of Medicine University of Alberta Edmonton Canada; Mazankowski Alberta Heart InstituteUniversity of Alberta Edmonton Canada From the Pulmonary Hypertension Program, University of Alberta, Edmonton, Canada. From the Department of Medicine (Cardiology) and the Vascular Biology Group, University of Alberta, Canada. Department of Medicine (Cardiology) and the Vascular Biology GroupUniversity of AlbertaEdmontonCanada From the Department of Medicine (Cardiology), University of Alberta, Edmonton, Canada. From the Cardiovascular Research Group (D.P.Y.K., J.R.B.D.) and the Vascular Biology Group (D.P.Y.K., S.B., J.N., E.D.M., J.R.B.D.), Faculty of Medicine and Dentistry, University of Alberta, Edmonton, Alberta, Canada; Department of Cell Biology (M.F.), Lerner Research Institute, The Cleveland Clinic Foundation, Cleveland, Ohio; and Baylor College of Medicine (M.E.Y.), Children’s Nutrition Research Center, Houston, Tex. From the Departments of Medicine and Pulmonary Hypertension Program (J.N., G.S., I.P., L.W., A.H., E.D.M.), Surgery (J.N., I.M.R., D.B.R.), and Pathology (B.C.), University of Alberta and Mazankowski Alberta Heart Institute, Edmonton, Canada; and Department of Medicine, University of Pittsburgh, Pittsburgh, PA (H.C.C.). From the Department of Medicine (Cardiology) and the Vascular Biology Group (E.D.M., A.N., X.W., G.H., A.L., R.G., S.L.A.), University of Alberta, Edmonton, Alberta, Canada; and Charles University, Physiology (V.H.), Prague, Czech Republic. From the Cardiology Division, Department of Medicine, University of Alberta, Edmonton, Canada. Department of Medicine, University of Alberta, Edmonton, Alberta T6G 2B7, Canada. From the Vascular Biology Group (B.T., E.D.M., X.-C.W., R.M., J.R.B.D., G.H., K.H., A.H., S.L.A.), Department of Physiology (S.L.A.), Department of Pediatrics (B.T., J.R.B.D.), Cardiovascular Research Group and Department of Pharmacology (J.R.B.D.), and Division of Cardiovascular Surgery (I.R.), University of Alberta, Edmonton, Alberta, Canada; and Ciphergen Biosystems Inc (M.K.), Freemont, Calif. From the Department of Medicine (Cardiology), University of Alberta, Edmonton, Alberta, Canada. From the Department of Medicine, University of Alberta, Edmonton, Alberta, Canada. From the Vascular Biology Group (S.L.A., F.S.G., X.W., K.H., E.D.M.), Cardiology (S.L.A., D.H.K., M.P., E.D.M., S.M.), Physiology (S.L.A.), and Cardiovascular Surgery (A.K., S.W.), University of Alberta, Edmonton, Canada; the Medical College of Wisconsin, Milwaukee (W.B.C.); and the University of Texas Southwestern Medical School, Dallas (J.R.F.). |
Incoming Links
Total number of triples: 164.